Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2025-12-26 @ 1:58 AM
NCT ID:
NCT04305405
Pre Assignment Details:
The study consisted of a screening period (up to 4 weeks), treatment period \[2 parts; Part A (16 weeks) followed by Part B (32 weeks)\], and a safety follow-up visit at Week 52.A total of 30 participants were enrolled in this study.
Recruitment Details:
This Phase III, open-label, parallel group study was conducted in pediatric participants with severe eosinophilic asthma at 17 investigational sites in the United States and Japan between 21 Nov 2019 and 12 Sep 2022.
Study:
NCT04305405
Study Brief:
Results Section:
NCT04305405